Realcan Pharmaceutical Group Co., Ltd. at its Annual General Meeting of 2022 held on 19 May 2023, approved the appointment of Zhang Shoukai, Li Zhe and Wu Liyan as Non-Independent Director, Liu Xijun, Wang Jifa and Sun Kaoxiang as Independent Director and Zhang Yan as Non-Employee Supervisor.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.76 CNY | -2.82% | +2.99% | -15.60% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.60% | 59Cr | |
+20.27% | 7.28TCr | |
-2.34% | 2.42TCr | |
+8.80% | 858.65Cr | |
+9.15% | 837.81Cr | |
-17.39% | 809.25Cr | |
+7.33% | 480.59Cr | |
+17.69% | 431.58Cr | |
-3.66% | 405.09Cr | |
-2.54% | 393.2Cr |
- Stock Market
- Equities
- 002589 Stock
- News Realcan Pharmaceutical Group Co., Ltd.
- Realcan Pharmaceutical Group Co., Ltd. Approves the Executive Appointments